Literature DB >> 23440623

The use of methylene blue in abdominal aortic surgery: a case report.

E Piraccini1, V Agnoletti, R Corso, S Maitan, G Gambale.   

Abstract

The open abdominal aortic surgery includes a well-known phase in which arterial blood flow is stopped by occluding clamps, resulting in peculiar physiologic changes usually superimposed on advanced pathologic conditions. An anesthetic plan should aim at providing hemodynamic stability and preserving organ function. Clamp removal leads to an acute fall in blood pressure following a decrease in systemic vascular resistance, caused by reactive hyperemia due to opening of the previously minimally perfused vascular beds. Several different mediators, including the nitrous oxide (NO) pathway, have been thought to be responsible for this hemodynamic effect. The massive production of NO by the inducible isoform of NO synthase could be partially responsible for the profound vasodilatation and myocardial dysfunction. The dye methylene blue (MB) has been used as to prevent vasodilatation in other clinical situations like sepsis, cardiopulmonary bypass and liver transplantation. We describe its use in a patient with poor hemodynamic status, who was submitted to aortic aneurism repair with infrarenal cross clamp. The intervention was also associated with a severe bleeding. In this case MB allowed us to control hypotension with relatively low doses of vasopressors.

Entities:  

Keywords:  aortic aneurysm; cardiovascular anesthesia; meischemia-reperfusion injury; methylene blue; vascular surgery

Year:  2010        PMID: 23440623      PMCID: PMC3484578     

Source DB:  PubMed          Journal:  HSR Proc Intensive Care Cardiovasc Anesth        ISSN: 2037-0504


  16 in total

1.  Angiotensin-converting enzyme inhibitors predispose to hypotension refractory to norepinephrine but responsive to methylene blue.

Authors:  Donatella Sparicio; Giovanni Landoni; Alberto Zangrillo
Journal:  J Thorac Cardiovasc Surg       Date:  2004-02       Impact factor: 5.209

Review 2.  Anesthesia for open abdominal aortic surgery.

Authors:  Michael F Wozniak; Glenn M LaMuraglia; Guido Musch
Journal:  Int Anesthesiol Clin       Date:  2005

3.  Nitric oxide in liver failure.

Authors:  S Midgley; I S Grant; W G Haynes; D J Webb
Journal:  Lancet       Date:  1991 Dec 21-28       Impact factor: 79.321

4.  Reversal of the haemodynamic features of acute liver failure by methylene blue.

Authors:  P V McGinn
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

5.  The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation.

Authors:  Heike Koelzow; Jacqueline A Gedney; Janos Baumann; Nicola J Snook; Mark C Bellamy
Journal:  Anesth Analg       Date:  2002-04       Impact factor: 5.108

Review 6.  Vasoplegic syndrome--the role of methylene blue.

Authors:  Ganesh Shanmugam
Journal:  Eur J Cardiothorac Surg       Date:  2005-09-06       Impact factor: 4.191

Review 7.  The pathophysiology of aortic cross-clamping and unclamping.

Authors:  S Gelman
Journal:  Anesthesiology       Date:  1995-04       Impact factor: 7.892

Review 8.  [Serotonin syndrome following methylene blue infusion during parathyroidectomy: a case report and literature review].

Authors:  Bradley K W Ng; Andrew J D Cameron; Rhea Liang; Habib Rahman
Journal:  Can J Anaesth       Date:  2008-01       Impact factor: 5.063

Review 9.  Neuro- and cardioprotective effects of blockade of nitric oxide action by administration of methylene blue.

Authors:  Lars Wiklund; Samar Basu; Adriana Miclescu; Per Wiklund; Gunnar Ronquist; Hari Shanker Sharma
Journal:  Ann N Y Acad Sci       Date:  2007-12       Impact factor: 5.691

10.  Aortic aneurysms, inflammatory pathways and nitric oxide.

Authors:  R D Sayers
Journal:  Ann R Coll Surg Engl       Date:  2002-07       Impact factor: 1.891

View more
  1 in total

Review 1.  Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.

Authors:  Jayme A Farina Junior; Andrea Carla Celotto; Marcelo Felix da Silva; Paulo Roberto B Evora
Journal:  Med Sci Monit       Date:  2012-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.